Fulgent Genetics Inc (FLGT) Stock Analysis

Fulgent Genetics Inc (FLGT) is a publicly traded company in the HEALTHCARE sector. It trades at $18.70, carries a market capitalization of $513.77M. This page summarizes the public market data, fundamentals, and frequently asked questions for FLGT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

Market Sentiment

Fulgent Genetics Inc currently has a Bullish sentiment score of 0.17.

About Fulgent Genetics Inc

Fulgent Genetics, Inc. is a leading provider of advanced genetic testing and diagnostic solutions, headquartered in Temple City, California. The company utilizes innovative technology to offer a wide range of testing services, including comprehensive genomics and COVID-19 diagnostics, aimed at delivering clinically actionable insights for healthcare providers. Fulgent's commitment to precision and innovation positions it as a key player in the rapidly advancing fields of genetic medicine and ...

GNG Research Analysis

GNG Research scores Fulgent Genetics Inc (FLGT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for FLGT.

Frequently Asked Questions

Does FLGT pay dividends?

Fulgent Genetics Inc (FLGT) does not currently pay a regular dividend.

What is FLGT's market cap?

Fulgent Genetics Inc (FLGT) has a market capitalization of $513.77M with a current stock price of $18.70.